Supplementary Figures
. Figure S1 . Efficacy of anti-angiogenic tyrosine kinase inhibitor therapy on tumor growth inhibition. Graph shows tumor volume as a function of treatment day and provided as a percentage of the control volume on the final experiment day for axitinib (4.5 µg/kg; n = 26; p = 0.74 and 36 µg/kg, n = 15; *p = 0.04), sunitinib (71 µg/kg; n = 9, p = 0.36), and erlotinib (40 µg/kg, n = 12; p = 0.44; 80 µg/kg, n = 12; p = 0.14). Values provided represent the mean tumor volume and error bars correspond to the standard error of the mean. 
